A diet rich in omega-3 foods during pregnancy has beneficial effects on the brain development of children and adolescents
The consumption of nuts during pregnancy, especially walnuts, benefits the neuropsychological development of children and adolescents, according to a study by the Institut d’Investigació Sanitària Pere Virgili (IISPV), titled Maternal prenatal nut and seafood consumption and child neuropsychological function from 4 to 15 years of age: a population-based cohort study, and published in The American Journal of Clinical Nutrition. The study, led by the Clinical and Epidemiological Neuroscience Research Group (NeuroÈpia) of the IISPV, includes contributions from Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation, and the California Walnut Commission, and is also included in the INMA project. This observational study focuses on the influence of maternal diet during gestation, a critical period for early brain development, and also highlights adolescence as another key stage when several brain regions continue to mature.
A sample of 1,737 mother-child pairs from four Spanish regions was studied: Asturias, Guipúzcoa (Basque Country), Sabadell (Catalonia) and Valencia. Maternal diet was analyzed using a food frequency questionnaire, while the children’s neuropsychological function was assessed through standardized tests measuring reaction time and variability (attention), working memory, and fluid intelligence.
The research took into account the consumption of fish—especially fatty fish—which, like walnuts, contains high levels of omega-3 fatty acids. These healthy fats have been shown to have a positive impact on the brain development of children and adolescents, according to the study’s findings. However, the researchers leading the project caution that fatty fish consumption should be approached carefully, and the recommended portions established by the WHO, via the European Food Safety Authority (EFSA) and the Spanish Agency for Food Safety and Nutrition (AESAN), should not be exceeded. Ariadna Pinar Martí, the study’s lead researcher, notes that high consumption of walnuts and fatty fish is associated with improvements in attention, working memory, and fluid intelligence. She adds that the omega-3 fatty acids present in these foods partially contribute to this relationship with neuropsychological development, particularly regarding attention.
Impact on risky decisions
The NeuroÈpia Research Group continues to investigate how maternal consumption of nuts and fish influences the brain development of offspring. They have also focused on the acquisition of more complex skills, such as risky decision-making in eleven-year-old children. In this regard, the article Maternal nut and fish consumption during pregnancy and child risky decision-making at 11 years old explores whether a maternal diet that includes these foods is associated with certain cognitive functions and behaviors, such as impulsivity. This study, led by researcher Marina Ruiz Rivera, has been published in the European Journal of Child and Adolescent Psychiatry. It emphasizes that the consumption of nuts and fish during pregnancy may have an effect on complex brain functions, such as decision-making.
The final sample consisted of 1,386 preteenagers and their mothers, with 1,081 participants specifically assessed for decision-making. According to Ruiz Rivera, higher maternal consumption of nuts during the first trimester of pregnancy was associated with a lower score in risky decisions in eleven-year-old children. Moderate fish consumption was associated with a higher impulsivity index in children of this age. Therefore, this study “adds to the evidence on the importance of nutrition during pregnancy for complex neuropsychological functions”. The study also emphasizes that “the available data are limited to eleven years of age, a stage in which the prefrontal cortex is not fully developed”, and therefore “a definitive causal relationship cannot be established”.
Looking ahead to future research in the field of nutrition, the NeuroÈpia Research Group highlights the importance of incorporating neuroimaging techniques. Applied specifically to the cohort studied in the two projects, “it will open up new scenarios for novel measurements, represent an innovation in this field, and allow us to examine whether diet during pregnancy influences not only cognitive functions but also brain structure”, emphasizes Jordi Julvez, head of the research group behind the two studies.
Bibliographic reference of the first study:
Pinar-Martí A, Ayala-Aldana N, Ruiz-Rivera M, Lertxundi N, Subiza M, González-Safont L, Vioque J, Riaño-Galán I, Rodríguez-Dehli C, Iglesias-Vázquez L, Arija V, Fernández-Barrés S, Romaguera D, Pascual-Rubio V, Fabregat-Sanjuan A, Healy D, Basagaña X, Vrijheid M, Guxens M, Foraster M, Julvez J. Maternal prenatal nut and seafood consumption and child neuropsychological function from 4 to 15 years of age: a population-based cohort study. Am J Clin Nutr. 2025 May 5:S0002-9165(25)00249-7. doi: 10.1016/j.ajcnut.2025.04.032. Epub ahead of print. PMID: 40334748.
Bibliographic reference of the second study:
Ruiz-Rivera M, Pinar-Martí A, Babarro I, Ibarluzea J, Vioque J, Llop S, Fernández-Somoano A, Tardón A, Pascual-Vicente R, Fabregat-Sanjuan A, Fernández-Barrés S, Romaguera D, Guxens M, Julvez J. Maternal nut and fish consumption during pregnancy and child risky decision-making at 11 years old. Eur Child Adolesc Psychiatry. 2025 Jun 10. doi: 10.1007/s00787-025-02750-5. Epub ahead of print. PMID: 40493090.
A URV-IISPV-CIBEROBN study warns that 80% of children’s products are not nutritionally adequate and should not be promoted
Most foods for children under three years of age marketed in Spain are of low nutritional quality and do not meet the standards set by the World Health Organization (WHO). This is indicated by a study led by the Rovira i Virgili University (URV) together with the Pere Virgili Health Research Institute (IISPV) and the CIBER of Obesity and Nutrition (CIBEROBN), which warns that these products should not be promoted for sale.
To carry out the study, which has been published in the European Journal of Pediatrics, more than 800 products were analyzed, including purees, dairy products, snacks and beverages. The research team detected repetitive nutritional problems in these foods, such as a high content of added sugars -often in the form of concentrated juices-, low caloric intake and low energy density. In addition, many of the product labels analyzed were the result of marketing strategies that were misleading because they showed confusing product names, such as “veal with carrots”, in cases where veal was a minority ingredient. They also found food packaging with messages such as “no added sugars” and even with unscientific health claims.
“Many of these products generate a false perception of quality, when in fact they are not suitable according to WHO for the healthy development of children,” warns Paulina Maria Leszczynska, first author of the study.
“No podemos permitir que los intereses comerciales prevalezcan sobre la salud infantil. Es imprescindible contar con una normativa clara, vinculante y basada en evidencias científicas que proteja a la población más pequeña”, advierte Nancy Babio, investigadora del Departamento de Bioquímica y Biotecnología de la URV e investigadora principal del proyecto.
Stopped regulation
Currently, food advertising in Spain is governed by the PAOS Code, a voluntary self-regulation system with no sanctioning mechanisms. In 2022 the Ministry of Consumer Affairs proposed a Royal Decree to regulate the advertising of food and beverages aimed at children, using the WHO criteria as a basis, but the processing of the text is still blocked pending approval by the Council of Ministers.
In view of these facts, the research team has called on the Government to approve without further delay the Royal Decree regulating the advertising of baby food and to prohibit the promotion of products that are not suitable for children under 3 years of age, especially those with excessive sugar or misleading claims.
The work has been carried out by the dietitian-nutritionist Paulina Maria Leszczyńska and the research team of the Department of Biochemistry and Biotechnology of the URV Sara de Heras-Delgado, Sangeetha Shyam, Jordi Salas-Salvadó and Nancy Babio, which is also part of the IISPV and CIBEROBN. The study has counted with Diane Threapleton and Janet Cade, from the University of Leeds, authors of the Nutrient and Promotion Profile Model Calculator tool, used to evaluate the nutritional and promotional performance of children’s products according to the WHO model.
Bibliographic Reference: Leszczyńska PM, de Las Heras-Delgado S, Shyam S, Threapleton D, Cade J, Salas-Salvadó J, Babio N. Nutricional contento y promocionar prácticas de foods para niños y jóvenes en el español mercado: en el cross-sectional product evaluation. Eur J Pediatr. 2025 May 10;184(6):333. doi: 10.1007/s00431-025-06156-y. PMID: 40347273; PMCID: PMC12065749.
This Wednesday, June 11, World Prostate Cancer Day, the importance of ensuring early detection is highlighted. The IISPV conducts research to find more effective and less invasive ways to predict advanced stage tumors and treat them earlier
Prostate cancer is the most common tumor among men in the province of Tarragona. Each year approximately 670 new cases are diagnosed there, a figure that represents almost one in four male cancers. On the commemoration of World Prostate Cancer Day, this Wednesday, June 11, the Institut d’Investigació Sanitària Pere Virgili (IISPV) recalls the importance of ensuring early detection of this type of cancer. In this sense, the IISPV has several active lines of research to better understand prostate cancer and to find more effective and less invasive ways to predict the prognosis of tumors and treat them in advance. This is highlighted by Dr. Matilde Rodríguez Chacón, head of the Disease Biomarkers and Molecular Mechanisms research group (DIBIOMEC) of the IISPV at the Hospital Universitari Joan XXIII de Tarragona, to whom the Spanish Association Against Cancer has recently granted a grant to develop a project focused on creating a new predictive tool for aggressive prostate cancer.
The main lines of research open to the group are, on the one hand, to find a safer and more accurate prognosis through innovative biomarkers – in this case through a novel test in semen – and, on the other, to delve into the hidden role of the fat that surrounds the prostate, which can act as a source of energy for the tumor, favoring its growth and aggressiveness. “What is of concern is not so much the presence of this fat on its own, but when it is part of a context of obesity or overweight. This does not mean that a person with obesity will necessarily develop prostate cancer, but it does mean that, if he or she does develop it, it is more likely to be more aggressive,” explains Dr. Rodríguez Chacón. For this reason, “controlling weight and maintaining healthy habits is key to reducing risks and facilitating a better prognosis”.
A safer and more reliable prognosis
Since 2016, the research group has been working closely with the Urology Service of the Joan XXIII Hospital in Tarragona on the development of a test designed to detect the aggressiveness of prostate cancer by analyzing biomarkers in liquid semen biopsy, with an accuracy of 90.9% to classify the aggressiveness of the tumor and allow its early treatment. Since its inception, this test has advanced significantly. Initially, seven biomarkers were considered, but thanks to the evolution of the group’s research, it has been reduced to three without losing prognostic efficacy. In addition, an algorithm has been designed that allows the application of these determinations in semen of the biomarkers in the clinical setting, with the aim of facilitating prognosis and personalization of treatment in affected patients. Now, the challenge for the research group is to validate the test with a larger number of samples through multicenter studies, a “necessary step, among others, to consolidate its use in routine medical practice”.
This research aims to reduce unnecessary biopsies, using less invasive and more reliable methods to detect aggressive tumors, as well as to offer personalized strategies for patients with non-aggressive tumors that do not require immediate surgery.
According to data from the Asociación Española contra el Cáncer in 2024, more than 34,000 cases of prostate cancer have been diagnosed in Spain, of which 5,400 were in Catalonia and 616 in Tarragona. It is estimated that between 2024 and 2029 there will be close to 150,000 new cases in Spain, with a notable increase among men under 70 years of age. Only 40% of men between 50 and 65 years of age in the province undergo regular check-ups, and this figure improves among those over 65, reaching 55%, although, according to experts, it is still insufficient.
The possible reason for the increase in cases in younger men, under 70 years of age, could be multifactorial. According to Dr. Rodríguez Chacón, this could be due to changes in lifestyle, improvements in diagnosis and early detection programs that identify tumors in earlier stages and in younger patients, as well as to environmental factors and genetic predisposition.
The event, which rewards notoriety and excellence, will hold its awards ceremony on June 12 at the Gaudí Auditorium of Tecnoparc firaReus
The lnstitut d’Investigació Sanitària Pere Virgili (IISPV) will be the beneficiary of the Premis Gaudí Gresol a la Notorietat i l’Excel·lència this year 2025, coinciding with 20 years of work in the field of biomedical research. The competition, which celebrates its 18th edition this year, will award the prizes on June 12 (7 p.m.) at the Gaudí auditorium of the firaReus complex.
The awards presentation ceremony, held on Wednesday, June 4 at the Ajuntament de Reus, was attended by the president of the Gresol Foundation, Emili Correig, the mayor of Reus, Sandra Guaita, the councilman of Empresa, Formació i Ocupació, Òscar Subirats and the general director of the Gresol Foundation, Robert Moragues.
The awards highlight the professional and personal careers, merits, worth and dedication of renowned entities and personalities, both in Catalonia and throughout Spain. The winners in this 18th edition are: in the category of Business Leadership, PortAventura World; in Technology, Andreu Veà; in Architecture, Ramon Espel; in Environment, Grupo Meliá; in Innovation, Andreu Rodríguez; in Gastronomy, Fran López; in Social Action, LaLiga Genuine; in Television, Olalla Moreno; in Fine Arts, Lorenzo Caprile; and, in Sports, Jordi Cervera.
Among the winners in past editions, there are personalities such as Pau Gasol, Valentí Fuster, Luis del Olmo, Ferran Adrià, Juan A. Samaranch, Isidre Fainé, Carles Sentís, Eduard Punset, Antoni Brufau, Mercè Sampietro, Joan Roca, Carme Ruscalleda, Anna Ferrer, Maribel Verdú, Elena Arzak, Josep M. Pou, Marc Márquez, Jordi Cruz, Gemma Mengual, Joan Pera, Manel Fuentes, Josep M. Mainat, M. De la Pau Janer, María Blasco, Jordi Basté, Marina Rossell, Tricicle, Susanna Griso or Juan Carlos Unzué among others.
This Saturday, May 31, is World No Tobacco Day and calls for preventive, educational and legislative measures to protect the health of children, reducing exposure to the toxic substances in smoke that persist once smoking is over.
The Institut d’Investigació Sanitària Pere Virgili (IISPV) continues its research on the effects produced by the toxic substances in tobacco, especially in children. On the occasion of the celebration of World No Tobacco Day, Noelia Ramírez, researcher at the IISPV and member of the research group in Pediatrics, Nutrition and Human Development (PEDINUR) of the University Rovira i Virgili (URV) and the IISPV, presented the latest results of her studies on the consequences of residual smoke.
Ramírez stresses that it is essential to be aware of the harmful effects that exist when exposed to nicotine, especially in the case of children under 5 years of age. In this sense, he explains that the so-called third-hand smoke is especially dangerous for the youngest children and is usually underestimated by parents and public authorities. The fact is that “this route of exposure is still not sufficiently well known. The toxic substances that make up this residual smoke also remain on objects and furniture surfaces, as well as the skin, mouth, lungs and clothing”. Ramírez stresses that, on world days like this one, it is important to protect the health of the population, especially children, with preventive measures, as well as educational and legislative measures.
Although anti-smoking policies have reduced exposure to smoke in public spaces, Ramirez says, many children are still exposed at home and outdoors.
Mayor riesgo de enfermedades respiratorias El impacto de este tipo de humo se traduce, en el caso de los más vulnerables, como los niños y niñas, en alteraciones del crecimiento, en un mayor riesgo de enfermedades respiratorias, malformaciones congénitas no cromosómicas (en caso de una exposición en la gestación) y caries dentales y enfermedades como otitis recurrentes.
El humo residual persiste, reacciona con otras sustancias del ambiente y cuesta eliminarlo, puesto que las sustancias tóxicas, como se apuntaba, resisten una limpieza superficial, como la ventilación, y también quedan partículas en movimiento, dependiendo de las temperaturas o flujos de ventilación. Además, cuando interactúan con una persona ésta también puede repartir en otros rincones estas sustancias.
Algunos de los consejos preventivos para evitar la presencia prolongada del humo de tercera mano son, entre otros, limitar los espacios donde se fuma, limpiar a fondo donde se haga -teniendo en cuenta materiales como alfombras y cortinas- y llevar en el caso de los fumadores, especialmente si tienen contacto con los más pequeños, una limpieza profunda y cuidadosa de manos, boca y ropa.
The Translational Research Laboratory in Cardiology has been officially inaugurated. It will be dedicated to conducting research projects focused on antithrombotic therapies for atherothrombotic cardiovascular diseases under the framework of the IISPV
In the province of Tarragona alone, thousands of patients receive antiplatelet therapy each year due to having suffered a cardiovascular atherothrombotic event, such as a myocardial infarction. An important consideration is that not all patients respond equally to these medications — especially P2Y12 receptor inhibitors. Patients who show a diminished response to the drug are at higher risk of experiencing further ischemic events (e.g., heart attacks or strokes), while those with an exaggerated response face an increased risk of bleeding complications. Therefore, it is crucial to conduct research in this area to enable truly personalized therapy, in which the most appropriate drugs, doses, and combinations are selected for each individual patient.
From this perspective, the Cardiology Department of Joan XXIII Hospital has launched the Translational Research Laboratory in Cardiology with the initial aim of investigating antithrombotic treatments for cardiovascular atherothrombotic diseases. Work is already underway to progressively incorporate new research lines focused on various cardiovascular pathologies from a translational approach — that is, research aimed at evaluating how laboratory advances can be applied in clinical practice. The laboratory, currently located in the Biobank area, will be able to perform a range of platelet function tests, which can be complemented by the analysis of genetic polymorphisms. This combination will help assess how patients respond to antithrombotic drugs and support the development of new treatment strategies. This initiative highlights the hospital’s commitment to promoting research, particularly in the field of precision medicine, which seeks to provide more personalized patient care.
As an example of the potential of this research line, it is worth noting that José Luis Ferreiro, Head of the Cardiology Department at the hospital, is one of the authors of a consensus document recently published in JACC: Cardiovascular Interventions — one of the most prestigious journals in the field of cardiology. The document focuses specifically on the standardization and interpretation of antiplatelet drug response, and outlines its main clinical indications for patients undergoing percutaneous coronary intervention. His participation in this document reflects his recognition as an international expert in the field.
The study includes a series of analyses of 483 liver samples and 169 serum and plasma samples
A study addresses the search for new non-invasive biomarkers to detect and monitor advanced-stage fatty liver disease, also known as MASH (metabolic dysfunction-associated steatohepatitis), one of the most concerning forms of metabolic dysfunction-associated liver disease. The study, titled Uncovering hepatic transcriptomic and circulating proteomic signatures in MASH: A meta-analysis and machine learning-based biomarker discovery, was led by the Study Group on Metabolic Diseases Associated with Insulin-Resistance (GEMMAIR, for its acronyms in catalan), under the direction of the Universitat Rovira i Virgili (URV), with the participation of the Institut d’Investigació Sanitària Pere Virgili (IISPV), and Teresa Auguet, Head of the Internal Medicine Service at the Hospital Universitari Joan XXIII and Associate Professor at URV. Published recently in Computers in Biology and Medicine, this project represents a step forward for precision medicine applied to metabolic liver diseases. By analyzing liver-specific data and circulating samples, researchers have identified distinctive features that can differentiate patients with MASH. In its severe stages, MASH can progress to more serious complications such as liver cirrhosis. Moreover, studies on liver samples may help identify potential therapeutic targets.
It should be noted that patients can suffer from fatty liver disease without being aware of it, since the symptoms at an early stage are minor or non-existent. For this reason, the research group with the study emphasizes the importance of improved detection.
Regarding the method employed in the work, a series of data was systematically reviewed and seven studies were retrieved, reaching 483 liver samples and 169 serum and plasma samples, respectively. In addition, the development of the project was managed through a machine learning model, which allows the identification of disease-specific biomarkers, using biologically significant protein ratios.
Potential tool for diagnosis This Machine Learning model has become a potential tool for the diagnosis of MASH stage disease. Further refinement and validation is still needed with larger samples to generalize these results. This approach may have a great impact on the clinical approach to MASH, thus benefiting a more careful stratification of the total number of patients seen, avoiding liver biopsies. It may even facilitate a personalized treatment approach, since the study of liver samples can help to identify possible therapeutic targets. With the project, the research group wants to pave the way for further research with more extensive data.
Bibliographic reference: Elena Cristina Rusu, Helena Clavero-Mestres, Mario Sánchez-Álvarez, Marina Veciana-Molins, Laia Bertran, Pablo Monfort-Lanzas, Carmen Aguilar, Javier Camaron, Teresa Auguet. Uncovering hepatic transcriptomic and circulating proteomic signatures in MASH: A meta-analysis and machine learning-based biomarker discovery, Computers in Biology and Medicine. DOI: https://doi.org/10.1016/j.compbiomed.2025.110170.
These are the results of a study by URV-IISPV after following 6,000 adults with metabolic syndrome for two years
Overweight and obesity have become a public health problem affecting more than 2.5 billion adults. Various studies have worked with the hypothesis that repeatedly consuming foods known as high glycemic index – which rapidly raise blood sugar levels after ingestion – could contribute to the development of obesity and, in the long term, diabetes or cardiovascular disease. Now, a research team from the Universitat Rovira i Virgili (URV) and the Institut d’Investigació Sanitària Pere Virgili (IISPV) has demonstrated that the consumption of pasta improves metabolic risk factors compared to potatoes, bread, or refined rice.
Breakfast cereals, sugary drinks, bread, refined rice, and potatoes, among others, are foods rich in rapidly absorbed carbohydrates. They cause a sudden increase in blood glucose and insulin levels, which stimulates appetite, fat storage, and reduces energy expenditure. This promotes obesity and hinders the use of glucose at the cellular level. Pasta, on the other hand, although also rich in carbohydrates, has a unique structure that causes these carbohydrates to be absorbed more slowly, resulting in a moderate glycemic response. When pasta is cooked to the “al dente” stage, the glycemic index is even lower, which would prevent this exaggerated glycemic response after consumption.
In the absence of rigorous studies evaluating the importance of pasta consumption on cardiovascular risk or weight gain, the research team evaluated 6,000 people at high risk of cardiovascular disease who were included in a weight loss program. They followed them over time to see if there was a relationship between refined pasta consumption and various cardiometabolic risk factors. They observed that those who consumed pasta more frequently had a greater reduction in body weight, as well as body mass index and waist circumference after two years of study. Additionally, replacing white bread, white rice, or potatoes with equivalent portions of pasta was associated with a greater reduction in the same parameters and an improvement in blood pressure and HDL cholesterol.
The study focused on older adults with cardiometabolic risk from the Mediterranean basin. Now, randomized clinical trials will be needed to verify if the results are the same in other populations.
The work is part of the multicollaborative PREDIMED-Plus study, involving 23 research institutions from Spain. The research was conducted by Sangeetha Shyam, Miguel Servet researcher at the Institut d’Investigació Sanitària Pere Virgili (IISPV), Stephanie K. Nishi, researcher at the School of Nutrition at the Metropolitan University of Toronto, and Jordi Salas-Salvadó, professor and director of the Human Nutrition Unit at URV. The team is part of the Biomedical Research Networking Center for the Physiopathology of Obesity and Nutrition (CIBERobn) and IISPV.
Bibliographic reference: Shyam S, Nishi SK, Ni J, Martínez-González MÁ, Corella D, Schröder H, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem L, Bueno-Cavanillas A, Tur JA, Martín Sánchez V, PintóX, Delgado-Rodríguez M, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Ros E, Gaforio JJ, Ruiz-Canela M, Fernández-Carrión R, Goday A, Garcia-Rios A, Torres-Collado L, Cueto-Galán R, Zulet MA, Prohens L, Casas R, Castillo-Hermoso MA, Tojal-Sierra L, Am GP, García-Arellano A, Sorlí JV, Castañer O, Arenas-Larriva AP, Oncina-Cánovas A, Goñi L, Fitó M, Babio N, Salas-Salvadó J. Pasta Consumption and Cardiometabolic Risks in Older Adults with Overweight/Obesity: A Longitudinal Analysis. J Am Nutr Assoc. 2025 Feb 19:1-13. DOI: 10.1080/27697061.2025.2463454.
The study, with the participation of Joan XXIII University Hospital and CIBER, analyzes 103 patients and highlights the relationship between hypertension and unfavorable disease progression
A study by the Infection and Immunity Research Group (INIM) of the Pere Virgili Health Research Institute (IISPV) has highlighted the relationship between hypertension, the most common pre-existing condition among COVID-19 patients, and a more severe progression of the disease, with a significant risk of hospitalization and death. The research team, led by Anna Rull and Joaquim Peraire, doctors at IISPV and the Joan XXIII University Hospital in Tarragona, and professors at the Rovira i Virgili University (URV), compared the molecules present in the bloodstream of hypertensive and non-hypertensive patients who experienced unfavorable progression of COVID-19.
For the study, samples from 103 patients were analyzed, including 63 who experienced unfavorable disease progression, of which 22 were hypertensive. The results show a clear association between hypertension and the severity of COVID-19, as 35% of patients who presented severe complications in the progression of COVID-19 had a prior diagnosis of hypertension.
The study has identified, in hypertensive patients, two molecules related to the activation of the cellular stress response, a key factor in the progression of COVID-19. Additionally, a comprehensive analysis of the lipid species content in blood has confirmed a critical role of phosphatidylcholines, the main component of cell membranes, in the immune system’s response to SARS-CoV-2 infection. Detecting molecules that show an altered pattern in blood at the onset of the disease can be a key strategy in diagnosing and anticipating severe complications. In this regard, the findings can help improve the prognosis and quality of life of hypertensive patients infected with the SARS-CoV-2 virus. However, the conclusions highlight the need for further research in the future with a larger sample of patients.
The study, recently published in the journal Scientific Reports (https://rdcu.be/ee3ZZ) by Springer Nature, is part of the research lines carried out by the Biomedical Research Network Center for Infectious Diseases (CIBERINFEC), with the participation of the INIM group of IISPV and the Translational Research Group in Immunology and Aging (TRIA) of IrsiCaixa. The work has involved collaboration with members of the Diabetes and Associated Metabolic Diseases Group (DIAMET), also from IISPV, which belongs to the Biomedical Research Network Center for Diabetes and Associated Metabolic Diseases (CIBERDEM).
The Pere Virgili Health Research Institute (IISPV) is the center that manages health and biomedical research in the province of Tarragona, bringing together the Joan XXIII University Hospital in Tarragona, Sant Joan de Reus Hospital, Pere Mata Institute in Reus, and Verge de la Cinta Hospital in Tortosa, as well as the Rovira i Virgili University. Since its creation in 2005, the Institute has worked to ensure that biomedical research translates into high-quality clinical practice for the benefit of patients and the improvement of public health. More than 600 professionals, including researchers, technicians, and trainees, are part of IISPV, which has 38 research groups distributed across four strategic areas: the area of Metabolic Diseases and Nutrition, with 16 research groups; the area of Infection, Immunity, and Environment, with a total of 10 groups; the area of Oncology, with 6 more research groups; and the area of Neurosciences and Mental Health, which integrates 6 research groups. IISPV is part of the network of Research Centers of Catalonia (CERCA).
During the visit, the Minister and the Government Delegate were able to learn about the Institute’s new projects, including the creation of the Clinical Research Unit and the expansion of the facilities at the Joan XXIII University Hospital campus
The Minister and the Government Delegate, accompanied by the director and members of the IISPV’s Advisory Management Committee
The Minister of Research and Universities of the Generalitat of Catalonia, Núria Montserrat, and the Government Delegate of the Generalitat in Tarragona, Lucía López, visited the facilities of the Pere Virgili Health Research Institute (IISPV) located at the Sant Joan University Hospital in Reus.
The director of IISPV, Joan Vendrell, accompanied by members of the Advisory Committee, presented some of the Institute’s most imminent projects, such as the creation of the new Clinical Research Unit and the expansion of IISPV’s facilities at the Joan XXIII University Hospital campus.
